COLA MICHAEL F
SEC insider (Form 3/4/5 filer). CIK 0001188940. Director at Phathom Pharmaceuticals, Inc. (PHAT) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 19, 2026. Located in FLORHAM PARK, NJ.
Companies COLA MICHAEL F has filed insider reports for
- Phathom Pharmaceuticals, Inc. (PHAT): Director
- Sage Therapeutics, Inc. (SAGE): Director
COLA MICHAEL F
CIK: 0001188940
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (25.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 19, 2026PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect24.1K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
21.5K shares- - Jun 11, 2025SAGE
Sage Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.5K shares- - Jun 3, 2025PHAT
Phathom Pharmaceuticals, Inc.
AwardDirect10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 19, 2026 |  PHAT Phathom Pharmaceuticals, Inc. | Award | 24,122 | - | $0 | Direct |
| Jul 31, 2025 |  SAGE Sage Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jun 11, 2025 | SAGE Sage Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jun 3, 2025 | PHAT Phathom Pharmaceuticals, Inc. | Award | 10,500 | - | - | Direct |
1-4 of 4 transactions